Cingulate Inc. SEC filings CINGW
Cingulate Inc. has 493 filings in SEC EDGAR's recent list, going back to May 24, 2021. Its latest annual report, Form ARS, was filed on May 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 24, 2026 | — |
| CORRESP | Letter to the SEC | Apr 22, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2026 | — |
| EFFECT | Filing | Mar 26, 2026 | — |
| CORRESP | Letter to the SEC | Mar 26, 2026 | — |
| EFFECT | Filing | Mar 24, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2026 | — |
| CORRESP | Letter to the SEC | Mar 23, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 14, 2026 | — |
| NT 10-Q | Filing | Aug 15, 2025 | Jun 30, 2025 |
| EFFECT | Filing | Jul 29, 2025 | — |
| CORRESP | Letter to the SEC | Jul 25, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2025 | — |
| EFFECT | Filing | Oct 7, 2024 | — |
| CORRESP | Letter to the SEC | Oct 3, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2024 | — |
| EFFECT | Filing | Aug 27, 2024 | — |
| CORRESP | Letter to the SEC | Aug 26, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2024 | — |
| EFFECT | Filing | Jul 24, 2024 | — |
| CORRESP | Letter to the SEC | Jul 22, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2024 | — |
| EFFECT | Filing | May 23, 2024 | — |
| CORRESP | Letter to the SEC | May 21, 2024 | — |
| UPLOAD | Letter from the SEC | May 21, 2024 | — |
| EFFECT | Filing | Apr 2, 2024 | — |
| EFFECT | Filing | Feb 2, 2024 | — |
| CORRESP | Letter to the SEC | Jan 30, 2024 | — |
| CORRESP | Letter to the SEC | Jan 30, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2024 | — |
| RW | Filing | Dec 6, 2023 | — |
| EFFECT | Filing | Sep 11, 2023 | — |
| CORRESP | Letter to the SEC | Sep 7, 2023 | — |
| CORRESP | Letter to the SEC | Sep 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2023 | — |
| EFFECT | Filing | May 17, 2023 | — |
| EFFECT | Filing | May 2, 2023 | — |
| CORRESP | Letter to the SEC | May 1, 2023 | — |
| UPLOAD | Letter from the SEC | May 1, 2023 | — |
| RW | Filing | Mar 30, 2023 | — |
| EFFECT | Filing | Jan 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 11, 2023 | — |
| CORRESP | Letter to the SEC | Jan 11, 2023 | — |
| DRS | Filing | Dec 8, 2022 | — |
| EFFECT | Filing | Apr 19, 2022 | — |
| POS EX | Filing | Dec 9, 2021 | — |
| SEC STAFF LETTER | Filing | Dec 8, 2021 | — |
| EFFECT | Filing | Dec 7, 2021 | — |
| CERT | Filing | Dec 6, 2021 | — |
| 8-A12B | Filing | Dec 3, 2021 | — |
| CORRESP | Letter to the SEC | Dec 3, 2021 | — |
| CORRESP | Letter to the SEC | Dec 3, 2021 | — |
| CORRESP | Letter to the SEC | Oct 14, 2021 | — |
| CORRESP | Letter to the SEC | Oct 14, 2021 | — |
| CORRESP | Letter to the SEC | Oct 12, 2021 | — |
| CORRESP | Letter to the SEC | Oct 12, 2021 | — |
| CORRESP | Letter to the SEC | Oct 6, 2021 | — |
| CORRESP | Letter to the SEC | Oct 6, 2021 | — |
| CERT | Filing | Oct 6, 2021 | — |
| CORRESP | Letter to the SEC | Oct 4, 2021 | — |
| CORRESP | Letter to the SEC | Oct 4, 2021 | — |
| 8-A12B | Filing | Oct 4, 2021 | — |
| CORRESP | Letter to the SEC | Oct 1, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2021 | — |
| D | Filing | Sep 28, 2021 | — |
| SEC STAFF LETTER | Filing | Sep 10, 2021 | — |
| CORRESP | Letter to the SEC | Sep 9, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2021 | — |
| DRSLTR | Filing | Aug 13, 2021 | — |
| DRS/A | Filing | Aug 13, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2021 | — |
| DRS/A | Filing | Jul 19, 2021 | — |
| DRSLTR | Filing | Jul 19, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2021 | — |
| DRS | Filing | May 24, 2021 | — |
Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CING (Nasdaq), CINGW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Kansas City, KS
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1862150
- Former names
- Cingulate Inc. (until Oct 2, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.